Go to Advanced Search
AHSA1 |
LOCUS ID | 10598 | ||||||||||||||||
GENE_SYMBOL | AHSA1 | ||||||||||||||||
GENE NAME | AHA1, activator of h | ||||||||||||||||
SYNONYMNS | p38, AHA1, hAha1, C14orf3 | ||||||||||||||||
CHROMOSOME | 14 | ||||||||||||||||
HOMOLOGENE ID | 8106 |
microRNAs | NA | NA |
GENE SUMMARY |
---|
AHSA1 (Activator Of HSP90 ATPase Activity 1) is a Protein Coding gene. Diseases associated with AHSA1 include Stomatitis and Cystic Fibrosis. Among its related pathways are T cell receptor signaling pathway and Mechanisms of CFTR activation by S-nitrosoglutathione (normal and CF). Gene Ontology (GO) annotations related to this gene include chaperone binding and ATPase activator activity. |
OBSERVATIONS |
---|
Complication | Evidence | PMID |
Nephropathy | 1. Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway. The activity of AP-1, a transcription factor complex that regulates several genes involved in diabetic nephropathy, is reversed when the p38 MAPK pathway is inhibited. These findings suggest the p38 MAPK pathway may be an important pathway involved in diabetic complications. | 11532081 |
Cardiovascular | There is increasing evidence that p38 MAPK plays a significant role in diabetic cardiomyopathy, including the regulation of diabetic complications such as cardiac hypertrophy, fibrosis, and apoptosis. | 27376265 |
Retinopathy | 1. p38 MAPK plays an important role in diabetes-induced inflammation in the retina, and inhibition of p38 MAPK offers a novel therapeutic approach to inhibiting the development of early stages of diabetic retinopathy and other complications of diabetes. | 20071676 |